Treace Medical Concepts Inc (TMCI)
7.83
-0.11
(-1.39%)
USD |
NASDAQ |
Nov 22, 16:00
7.83
0.00 (0.00%)
After-Hours: 20:00
Treace Medical Concepts Cash from Operations (Quarterly): -11.84M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -11.84M |
June 30, 2024 | -13.90M |
March 31, 2024 | -7.221M |
December 31, 2023 | 0.532M |
September 30, 2023 | -9.513M |
June 30, 2023 | -8.335M |
March 31, 2023 | -17.26M |
December 31, 2022 | -5.358M |
September 30, 2022 | -7.483M |
June 30, 2022 | -10.57M |
Date | Value |
---|---|
March 31, 2022 | -7.241M |
December 31, 2021 | -3.752M |
September 30, 2021 | -9.264M |
June 30, 2021 | -3.731M |
March 31, 2021 | -0.446M |
December 31, 2020 | 2.448M |
September 30, 2020 | -4.202M |
June 30, 2020 | -1.845M |
March 31, 2020 | -0.895M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-17.26M
Minimum
Mar 2023
2.448M
Maximum
Dec 2020
-6.309M
Average
-7.221M
Median
Mar 2024
Cash from Operations (Quarterly) Benchmarks
Stryker Corp | 1.474B |
Perspective Therapeutics Inc | 3.366M |
Retractable Technologies Inc | -5.727M |
Xtant Medical Holdings Inc | -1.718M |
Catheter Precision Inc | -2.768M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | 5.763M |
Cash from Financing (Quarterly) | 0.008M |
Free Cash Flow | -43.20M |
Free Cash Flow Per Share (Quarterly) | -0.2363 |
Free Cash Flow to Equity (Quarterly) | -14.78M |
Free Cash Flow Yield | -8.90% |